| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $85.6M | -6.2% |
| Cost of Revenue | $62.3M | -19.1% |
| Gross Profit | $23.3M | +63.1% |
| R&D Expense | $2.7M | +8.3% |
| SG&A Expense | $26.2M | -18.6% |
| Operating Income | -$5.6M | +72.6% |
| Pre-tax Income | -$7.0M | -194.7% |
| Income Tax | $175K | +1150.0% |
| Net Income | -$7.2M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $7.0M | +7.4% |
| Inventory | $16.6M | -19.5% |
| Current Assets | $36.1M | +3.9% |
| Total Assets | $74.9M | -11.1% |
| Current Liabilities | $52.6M | -28.2% |
| Long-term Debt | $32.2M | +11.3% |
| Total Liabilities | $82.6M | -2.8% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.7M | +127.8% |
| Capital Expenditures | $879K | -81.2% |
| Investing Cash Flow | -$879K | +81.2% |
| Financing Cash Flow | -$223K | -101.0% |
| Free Cash Flow | $6.8M | +121.1% |
| -197.3% |
| EPS (Basic) | -$0.38 | -197.4% |
| EPS (Diluted) | -$0.38 | -197.4% |
| Stockholders' Equity |
| -$21.6M |
| -47.6% |